KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Cash & Equivalents (2016 - 2025)

Repligen (RGEN) has disclosed Cash & Equivalents for 16 consecutive years, with $767.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 1.36% to $767.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $767.6 million through Dec 2025, up 1.36% year-over-year, with the annual reading at $767.6 million for FY2025, 1.36% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $767.6 million at Repligen, up from $748.7 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $809.1 million in Q2 2024, with the low at $516.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $675.2 million, with a median of $703.0 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents decreased 18.77% in 2022, then surged 51.1% in 2024.
  • Over 5 years, Cash & Equivalents stood at $603.8 million in 2021, then fell by 13.31% to $523.5 million in 2022, then soared by 43.53% to $751.3 million in 2023, then increased by 0.8% to $757.4 million in 2024, then grew by 1.36% to $767.6 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $767.6 million, $748.7 million, and $708.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.